Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | -13.7B | 12.1B | 26.5B | 18.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.3B | 1.3B | 1.2B | 1.3B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 1.1B | 1.0B | 1.0B | 956M |
| Other income expense | 2.6B | 2.8B | 2.5B | 2.4B |
| Pretax income | 1.1B | 1.9B | 1.2B | 2.5B |
| Tax provision | 152M | 511M | 135M | 295M |
| Net income | 976M | 1.3B | 1.1B | 2.2B |
| Basic EPS | 2.3 | 3.1 | 2.5 | 4.9 |
| Diluted EPS | 2.3 | 3.1 | 2.5 | 4.9 |
| Basic average shares | 433.5M | 435.5M | 436.4M | 443.6M |
| Diluted average shares | 433.5M | 435.5M | 436.4M | 443.6M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 9M | 1M | — | — |
| Preferred stock dividends | 7M | 7M | 7M | 7M |